Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/blood-2016-01-678151 http://scihub22266oqcxt.onion/10.1182/blood-2016-01-678151 C4882802!4882802!27053532     free     free     free       Blood 2016 ; 127 (21): 2525-35 Nephropedia Template TP {{tp|p=27053532|t=2016. A genome editing primer for the hematologist |pdf=|usr=}}{{27053532}} gab.com Text A genome editing primer for the hematologist JO: Blood http://www.kidney.de/pget.php?&tw=1&pmid=27053532 #FOAvip Gene editing enables the site-specific modification of the genome. These technologies have rapidly advanced such that they have entered common use in experimental hematology to investigate genetic function. In addition, genome editing is becoming increasingly plausible as a treatment modality to rectify genetic blood disorders and improve cellular therapies. Genome modification typically ensues from site-specific double-strand breaks and may result in a myriad of outcomes. Even single-strand nicks and targeted biochemical modifications that do not permanently alter the DNA sequence (epigenome editing) may be powerful instruments. In this review, we examine the various technologies, describe their advantages and shortcomings for engendering useful genetic alterations, and consider future prospects for genome editing to impact hematology. Twit Text FOAVip A genome editing primer for the hematologist ????Blood http://www.kidney.de/pget.php?&tw=1&pmid=27053532 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27053532 #FOAvip English Wikipedia <ref>{{Cite pmid|27053532}}</ref> A genome editing primer for the hematologist #MMPMID27053532 Hoban MD; Bauer DE Blood 2016[May]; 127 (21): 2525-35 PMID27053532show ga Gene editing enables the site-specific modification of the genome. These technologies have rapidly advanced such that they have entered common use in experimental hematology to investigate genetic function. In addition, genome editing is becoming increasingly plausible as a treatment modality to rectify genetic blood disorders and improve cellular therapies. Genome modification typically ensues from site-specific double-strand breaks and may result in a myriad of outcomes. Even single-strand nicks and targeted biochemical modifications that do not permanently alter the DNA sequence (epigenome editing) may be powerful instruments. In this review, we examine the various technologies, describe their advantages and shortcomings for engendering useful genetic alterations, and consider future prospects for genome editing to impact hematology. äA genome editing primer for the hematologist (epmc).pdf DeepDyve Pubget Overpricing